[A late phase II study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase II].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples